EDN2 and cancer: Mixed results have been found for another 10 (HOTS, EDN2, TGM3, CHL1, SOX21-AS1, ZBTB16, PEG3, ATF3, CCNA1, KCNK7), which are upregulated in some cancers, but downregulated in others.